One

              Centrum f. int. Onko

 

                          Tüv 

 

          FOCUS 2018

                 DKG

 

                   CK CARE

 

                  GALEN.png

 

 
Two
Sie sind hier: Startseite Forschung Publikationen Publikationen 2018

Publikationen 2018

Allam, J. P.; Andreasen, J. N.; Mette, J.; Serup-Hansen, N.; Wüstenberg, E. G. (2018): Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany. In: J Allergy Clin Immunol. 141 (5), 1898-1901.e5. Online verfügbar unter PM:29410285; ISI:000432148200037.

Allam, J. P.; Ochsendorf, F. R.; Köhn, F. M. (2018): [What does dermatology have to do with andrology?]. In: Hautarzt. 69 (12), S. 970–971. Online verfügbar unter PM:30406810; ISI:000451584000002.

Allam, J. P.; Wolf, H.; Wustenberg, E. (2018): SQ (R) house-dust-mite SLIT-tablet: Overview of the results of the clinical trials in patients with house-dust mite-induced allergic rhinitis and asthma. In: Rev Fr Allergol. 41 (1), S. 40–48. Online verfügbar unter ISI:000425274900007.

Augustin, M.; Wilsmann-Theis, D.; Körber, A.; Kerscher, M.; Itschert, G.; Dippel, M.; Staubach, P. (2018): Positionspapier: Diagnostik und Therapie der Xerosis cutis. In: J Dtsch Dermatol Ges. 16 Suppl 4, S. 3–35. Online verfügbar unter PM:29989340; ISI:000438031800001.

Berekméri, A.; Latzko, A.; Alase, A.; Macleod, T.; Ainscough, J. S.; Laws, P. et al. (2018): Detection of IL-36? through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema. In: J Allergy Clin Immunol. 142 (3), 988-991.e4. Online verfügbar unter PM:29782895; ISI:000443726500034.

Bousquet, J.; Agache, I.; Aliberti, M. R.; Angles, R.; Annesi-Maesano, I.; Anto, J. M. et al. (2018): Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). In: Allergy. 73 (1), S. 77–92. Online verfügbar unter PM:28600902; ISI:000418442300008.

Bousquet, J.; Devillier, P.; Anto, J. M.; Bewick, M.; Haahtela, T.; Arnavielhe, S. et al. (2018): Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study. In: Allergy. 73 (8), S. 1622–1631. Online verfügbar unter PM:29569295; ISI:000438710600004.

Braegelmann, C.; Jaschke, K.; Simon, B.; Hornung, T.; Bieber, T.; Wenzel, J. (2018): Test Your Knowledge. In: Pneumologie. 72 (11), S. 757–759. Online verfügbar unter PM:30408829; ISI:000449505200016.

Braegelmann, J.; Braegelmann, C.; Bieber, T.; Wenzel, J. (2018): Candida induces the expression of IL-36? in human keratinocytes: implications for a pathogen-driven exacerbation of psoriasis? In: J Eur Acad Dermatol Venereol. 32 (11), e403-e406. Online verfügbar unter PM:29633390; ISI:000448786400004.

Cabanillas, B.; Cuadrado, C.; Rodriguez, J.; Dieguez, M. C.; Crespo, J. F.; Novak, N. (2018): Boiling and Pressure Cooking Impact on IgE Reactivity of Soybean Allergens. In: Int Arch Allergy Immunol. 175 (1-2), S. 36–43. Online verfügbar unter PM:29342467; ISI:000425496100006.

Cabanillas, B.; Jappe, U.; Novak, N. (2018): Allergy to Peanut, Soybean, and Other Legumes: Recent Advances in Allergen Characterization, Stability to Processing and IgE Cross-Reactivity. In: Mol Nutr Food Res. 62 (1). Online verfügbar unter PM:28944625; ISI:000419727500013.

Cabanillas, B.; Maleki, S. J.; Cheng, H.; Novak, N. (2018): Differences in the Uptake of Ara h 3 from Raw and Roasted Peanut by Monocyte-Derived Dendritic Cells. In: Int Arch Allergy Immunol. 177 (1), S. 35–39. Online verfügbar unter PM:29879702; ISI:000442609700004.

Colpi, G. M.; Francavilla, S.; Haidl, G.; Link, K.; Behre, H. M.; Goulis, D. G. et al. (2018): European Academy of Andrology guideline Management of oligo-astheno-teratozoospermia. In: Andrology. 6 (4), S. 513–524. Online verfügbar unter PM:30134082; ISI:000440403300001.

Franzen, A.; Vogt, T. J.; Müller, T.; Dietrich, J.; Schröck, A.; Golletz, C. et al. (2018): and promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas. In: Oncotarget. 9 (1), S. 641–650. Online verfügbar unter PM:29416641; ISI:000419615500051.

Froehlich, A.; Schmidt, S.; Landsberg, J.; Bieber, T.; Wenzel, J. (2018): Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod. In: Mult Scler. 24 (13), S. 1785–1787. Online verfügbar unter PM:29722598; ISI:000450358800021.

Gattinger, P.; Lupinek, C.; Kalogiros, L.; Silar, M.; Zidarn, M.; Korosec, P. et al. (2018): The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis. In: PLoS ONE. 13 (6), e0199250. Online verfügbar unter PM:29940036; ISI:000436088700011.

Gilles, S.; Akdis, C.; Lauener, R.; Schmid-Grendelmeier, P.; Bieber, T.; Schäppi, G.; Traidl-Hoffmann, C. (2018): The role of environmental factors in allergy: A critical reappraisal. In: Exp Dermatol. 27 (11), S. 1193–1200. Online verfügbar unter PM:30099779; ISI:000447846400001.

Goltz, D.; Gevensleben, H.; Vogt, T. J.; Dietrich, J.; Golletz, C.; Bootz, F. et al. (2018): CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients. In: JCI Insight. 3 (13). Online verfügbar unter PM:29997292; ISI:000438547200015.

Grobe, W.; Allam, J. P.; Haidl, G. (2018): [Skin diseases and fertility/hormone disorders]. In: Hautarzt. 69 (12), S. 991–995. Online verfügbar unter PM:30397747; ISI:000451584000006.

Haufe, E.; Abraham, S.; Heratizadeh, A.; Harder, I.; Zink, A.; Weisshaar, E. et al. (2018): [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]. In: Hautarzt. 69 (10), S. 815–824. Online verfügbar unter PM:30191254; ISI:000452379400005.

Hiller, B.; Hoppe, A.; Haase, C.; Hiller, C.; Schubert, N.; Müller, W. et al. (2018): Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin. In: Cancer Res. 78 (20), S. 5917–5926. Online verfügbar unter PM:30154151; ISI:000447552500017.

Iwamoto, K.; Nümm, T. J.; Koch, S.; Herrmann, N.; Leib, N.; Bieber, T. (2018): Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized toward TLR2 activation. In: Allergy. 73 (11), S. 2205–2213. Online verfügbar unter PM:29672867; ISI:000450344300010.

Kunz, M.; Löffler-Wirth, H.; Dannemann, M.; Willscher, E.; Doose, G.; Kelso, J. et al. (2018): RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas. In: Oncogene. 37 (47), S. 6136–6151. Online verfügbar unter PM:29995873; ISI:000450883000003.

Leib, N.; Herrmann, N.; Koch, S.; Stroisch, T. J.; Schnautz, S.; Wilms, H.; Bieber, T. (2018): MicroRNA-155 mediates downregulation of the high-affinity receptor for IgE through Toll-like receptor signaling. In: J Allergy Clin Immunol. 141 (1), 425-429.e6. Online verfügbar unter PM:28889954; ISI:000419312200054.

Lustig, L.; Allam, J. P. (2018): Guest editors foreword. In: Andrologia. 50 (11), e13186. Online verfügbar unter PM:30569648; ISI:000453795800004.

Mössner, R.; Wilsmann-Theis, D.; Oji, V.; Gkogkolou, P.; Löhr, S.; Schulz, P. et al. (2018): The genetic basis for most patients with pustular skin disease remains elusive. In: Br J Dermatol. 178 (3), S. 740–748. Online verfügbar unter PM:28887889; ISI:000428701000053.

Müller, S.; Allam, J. P.; Bunzek, C. G.; Clemons, T. E.; Holz, F. G.; Charbel Issa, P. (2018): SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2. In: Retina. 38 Suppl 1, S61-S66. Online verfügbar unter PM:28837534; ISI:000440615000010.

Niebel, D.; Wenzel, J. (2018): [Immunopathology of cutaneous drug eruptions]. In: Pathologe. 39 (6), S. 563–570. Online verfügbar unter PM:30215117; ISI:000450713000009.

Niederberger, V.; Neubauer, A.; Gevaert, P.; Zidarn, M.; Worm, M.; Aberer, W. et al. (2018): Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. In: J Allergy Clin Immunol. 142 (2), 497-509.e9. Online verfügbar unter PM:29361332; ISI:000440664400018.

Pigors, M.; Common, J. E.A.; Wong, XFCC; Malik, S.; Scott, C. A.; Tabarra, N. et al. (2018): Exome Sequencing and Rare Variant Analysis Reveals Multiple Filaggrin Mutations in Bangladeshi Families with Atopic Eczema and Additional Risk Genes. In: J Invest Dermatol. 138 (12), S. 2674–2677. Online verfügbar unter PM:29857066; ISI:000450431000041.

Rabe, E.; Carpentier, P.; Maggioli, A. (2018): Understanding lower leg volume measurements used in clinical studies focused on venous leg edema. In: Int Angiol. 37 (6), S. 437–443. Online verfügbar unter PM:30256052; ISI:000456079900003.

Rabe, E.; Partsch, H.; Hafner, J.; Lattimer, C.; Mosti, G.; Neumann, M. et al. (2018): Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement. In: Phlebology. 33 (3), S. 163–184. Online verfügbar unter PM:28549402; ISI:000429910800002.

Röver, L. K.; Gevensleben, H.; Dietrich, J.; Bootz, F.; Landsberg, J.; Goltz, D.; Dietrich, D. (2018): PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations. In: EBioMedicine. 28, S. 97–104. Online verfügbar unter PM:29396294; ISI:000425875600020.

Sanchiz, A.; Cuadrado, C.; Dieguez, M. C.; Ballesteros, I.; Rodríguez, J.; Crespo, J. F. et al. (2018): Thermal processing effects on the IgE-reactivity of cashew and pistachio. In: Food Chem. 245, S. 595–602. Online verfügbar unter PM:29287414; ISI:000418471100073.

Schmitt, J.; Haufe, E.; Trautmann, F.; Schulze, H. J.; Elsner, P.; Drexler, H. et al. (2018): Occupational UV-Exposure is a Major Risk Factor for Basal Cell Carcinoma: Results of the Population-Based Case-Control Study FB-181. In: J Occup Environ Med. 60 (1), S. 36–43. Online verfügbar unter PM:29111985; ISI:000419431400016.

Schmitt, J.; Haufe, E.; Trautmann, F.; Schulze, H. J.; Elsner, P.; Drexler, H. et al. (2018): Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181. In: Br J Dermatol. 178 (2), S. 462–472. Online verfügbar unter PM:28845516; ISI:000425009400081.

Schwahn-Schreiber, C.; Breu, F. X.; Rabe, E.; Buschmann, I.; Döller, W.; Lulay, G. R. et al. (2018): [S1 guideline on intermittent pneumatic compression (IPC)]. In: Hautarzt. 69 (8), S. 662–673. Online verfügbar unter PM:29951853; ISI:000440978900012.

Simon, H. U.; Bieber, T. (2018): Allergy-Committed to progress in allergy and immunology. In: Allergy. 73 (3), S. 527. Online verfügbar unter PM:29330864; ISI:000425622700002.

Simpson, E. L.; Flohr, C.; Eichenfield, L. F.; Bieber, T.; Sofen, H.; Taïeb, A. et al. (2018): Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE). In: J Am Acad Dermatol. 78 (5), 863-871.e11. Online verfügbar unter PM:29353026; ISI:000430421900020.

Sirokay-Kohlmeyer, J. (2018): [Current aspects in the prognosis of advanced melanoma]. In: Hautarzt. 69 (3), S. 249–259. Online verfügbar unter PM:29396638; ISI:000427365100016.

Stucker, M.; Mumme, A.; Mendoza, E.; Hartmann, K.; Pannier, F.; Rabe, E.; Gerlach, H. (2018): Additional medical education phlebology is saved. In: Phlebologie. 47 (4), S. 176–180. Online verfügbar unter ISI:000442537300001.

Tofte, S. J.; Papp, K.; Sadick, N.; Bohnert, K.; Simpson, E.; Thaçi, D. et al. (2018): Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials. In: J Am Assoc Nurse Pract. 30 (9), S. 529–541. Online verfügbar unter PM:30211823; ISI:000456058900009.

Vogt, T. J.; Gevensleben, H.; Dietrich, J.; Kristiansen, G.; Bootz, F.; Landsberg, J. et al. (2018): Detailed analysis of adenosine A2a receptor and CD73 (5'-nucleotidase, ecto, ) methylation and gene expression in head and neck squamous cell carcinoma patients. In: Oncoimmunology. 7 (8), e1452579. Online verfügbar unter PM:30221045; ISI:000443907300010.

Weidinger, S.; Beck, L. A.; Bieber, T.; Kabashima, K.; Irvine, A. D. (2018): Atopic dermatitis. In: Nat Rev Dis Primers. 4 (1), S. 1. Online verfügbar unter PM:29930242; ISI:000436198100001.

Wenzel, J.; Landmann, A.; Vorwerk, G.; Kuhn, A. (2018): High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus. In: Exp Dermatol. 27 (1), S. 95–97. Online verfügbar unter PM:28833566; ISI:000418867700016.

Werninghaus, I.; Maier, J.; Wilsmann-Theis, D.; Wenzel, J. (2018): Tumour necrosis factor-?-inhibitor-induced neutrophilic folliculitis presenting with strong lesional expression of interleukin-36? In: Clin Exp Dermatol. 43 (4), S. 458–459. Online verfügbar unter PM:29315748; ISI:000431979500016.

Wilsmann-Theis, D.; Schnell, L. M.; Ralser-Isselstein, V.; Bieber, T.; Schön, M. P.; Hüffmeier, U.; Mössner, R. (2018): Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations. In: J Dermatol. 45 (7), S. 850–854. Online verfügbar unter PM:29655177; ISI:000437296200029.

Wolk, K.; Frambach, Y.; Jacobi, A.; Wilsmann-Theis, D.; Phillipp, S.; Witte-Händel, E. et al. (2018): Increased levels of lipocalin 2 in palmoplantar pustular psoriasis. In: J Dermatol Sci. 90 (1), S. 68–74. Online verfügbar unter PM:29395573; ISI:000430151800009.

Wollenberg, A.; Barbarot, S.; Bieber, T.; Christen-Zaech, S.; Deleuran, M.; Fink-Wagner, A. et al. (2018): Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. In: J Eur Acad Dermatol Venereol. 32 (5), S. 657–682. Online verfügbar unter PM:29676534; ISI:000430468700035.

Wollenberg, A.; Barbarot, S.; Bieber, T.; Christen-Zaech, S.; Deleuran, M.; Fink-Wagner, A. et al. (2018): Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. In: J Eur Acad Dermatol Venereol. 32 (6), S. 850–878. Online verfügbar unter PM:29878606; ISI:000434141600032.

Yu, C. F.; Peng, W. M.; Schlee, M.; Barchet, W.; Eis-Hübinger, A. M.; Kolanus, W. et al. (2018): SOCS1 and SOCS3 Target IRF7 Degradation To Suppress TLR7-Mediated Type I IFN Production of Human Plasmacytoid Dendritic Cells. In: J Immunol. 200 (12), S. 4024–4035. Online verfügbar unter PM:29712772; ISI:000442386300017.

Artikelaktionen